ADAR1 Capital Management LLC insider trades

Open-market stock purchases and sales by ADAR1 Capital Management LLC, 10% Owner at InMed Pharmaceuticals Inc, from SEC Form 4 filings since Aug 9, 2024.

Track record: 92% of 38 scored buys are up 5% or more since purchase, averaging +11%.

Recent trades

DateStockTradeValue
Sep 16, 2026INM InMed Pharmaceuticals IncBought$10.8K
Sep 15, 2026INM InMed Pharmaceuticals IncBought$70.4K
Sep 14, 2026INM InMed Pharmaceuticals IncBought$36.9K
Sep 3, 2026TENX Tenax Therapeutics, IncBought$1.6M
Sep 2, 2026TENX Tenax Therapeutics, IncBought$338K
Sep 1, 2026TENX Tenax Therapeutics, IncBought$322K
Aug 31, 2026TENX Tenax Therapeutics, IncBought$723K
Aug 24, 2026TENX Tenax Therapeutics, IncBought$188K
Aug 21, 2026TENX Tenax Therapeutics, IncBought$1.3M
Aug 20, 2026TENX Tenax Therapeutics, IncBought$360K
Jul 31, 2026NXTC NextCure, IncBought$16.4K
Jul 31, 2026NXTC NextCure, IncBought$125K
Jul 31, 2026NXTC NextCure, IncBought$38.4K
Jul 30, 2026NXTC NextCure, IncBought$249K
Jul 30, 2026NXTC NextCure, IncBought$100K
Jul 30, 2026NXTC NextCure, IncBought$120K
Jul 30, 2026NXTC NextCure, IncBought$490K
Jul 30, 2026NXTC NextCure, IncBought$386K
Jul 29, 2026NXTC NextCure, IncBought$8K
Jul 29, 2026NXTC NextCure, IncBought$9.1K
Jul 28, 2026NXTC NextCure, IncBought$31.7K
Jul 27, 2026NXTC NextCure, IncBought$39K
Jul 15, 2026INM InMed Pharmaceuticals IncBought$1.6K
May 19, 2026INM InMed Pharmaceuticals IncBought$110K
May 19, 2026INM InMed Pharmaceuticals IncBought$300K

Companies traded

  • INM InMed Pharmaceuticals Inc: 6 buys, last Sep 16, 2026
  • TENX Tenax Therapeutics, Inc: 7 buys, last Sep 3, 2026
  • NXTC NextCure, Inc: 12 buys, last Jul 31, 2026
  • RLYB Rallybio Corp: 14 buys, last May 19, 2026
  • KROS Keros Therapeutics, Inc: 5 buys, 3 sales, last Oct 15, 2025
  • PIRS Pieris Pharmaceuticals, Inc: 3 buys, last Aug 12, 2024

Get free alerts when ADAR1 Capital Management LLC files a new trade →